RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,277 | -31.0% | 124,331 | -17.6% | 0.00% | -100.0% |
| Q2 2023 | $194,547 | -68.9% | 150,812 | -68.1% | 0.00% | -66.7% |
| Q1 2023 | $624,843 | -8.1% | 473,366 | -17.9% | 0.00% | -25.0% |
| Q3 2022 | $680,000 | +103.0% | 576,606 | +414.8% | 0.00% | +33.3% |
| Q1 2022 | $335,000 | +23.2% | 112,005 | +8.9% | 0.00% | +50.0% |
| Q4 2021 | $272,000 | -32.8% | 102,816 | -7.7% | 0.00% | -60.0% |
| Q3 2021 | $405,000 | +382.1% | 111,449 | +475.3% | 0.01% | +400.0% |
| Q2 2021 | $84,000 | -73.1% | 19,373 | -78.8% | 0.00% | -80.0% |
| Q1 2021 | $312,000 | +115.2% | 91,185 | +120.1% | 0.01% | +150.0% |
| Q4 2020 | $145,000 | – | 41,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |